Multifactorial hypophosphatemia: a diagnostic challenge involving denosumab, iron infusion, renal tubular acidosis, and gastrointestinal losses
Abstract
Hypophosphatemia is a complex electrolyte disturbance with diverse etiologies, including decreased intestinal absorption, increased renal loss, intracellular redistribution, and medication effects. We present a diagnostically challenging case of severe, persistent hypophosphatemia in a 39-yr-old female with a history of renal transplantation, chronic gastrointestinal disease, and osteoporosis. The patient presented with acute abdominal pain, nausea, and constipation and was found to have profound hypophosphatemia (<0.3 mmol/L), hypocalcemia, and hypokalemia. Her recent medical history included administration of i.v. ferric carboxymaltose and denosumab, both known to induce hypophosphatemia via FGF23-mediated renal phosphate wasting and secondary hyperparathyroidism. Additional contributing factors in her case included renal tubular acidosis, tertiary hyperparathyroidism, tacrolimus-induced tubular dysfunction, and significant gastrointestinal losses due to prior bowel resections and acute ileus. Despite aggressive i.v. and oral phosphate supplementation, hypophosphatemia persisted, necessitating prolonged therapy and multiple hospital admissions. Reduction of tacrolimus and correction of acidosis improved phosphate reabsorption, but recurrent episodes highlighted the multifactorial nature of her condition. This case underscores the importance of a systematic, multidisciplinary approach to diagnosing and managing hypophosphatemia, particularly in patients with overlapping…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Irisin Enhances Osteoblast DifferentiationIn Vitro
- Glucocorticoids suppress Wnt16 expression in osteoblasts in vitro and in vivo
- Interaction between Schwann Cells and Osteoblasts In Vitro
- Administration of cinnamaldehyde promotes osteogenesis in ovariectomized rats and differentiation of osteoblast in vitro
- The Effect of the Major Components of Fructus Cnidii on Osteoblasts In Vitro
- Estrogen depletion alters osteogenic differentiation and matrix production by osteoblasts in vitro
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.